mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.7 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.7 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.7 |